Listed

Phio Pharmaceuticals Corp.

PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31

Reports and events: 316 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Phio Pharmaceuticals Corp., Reports and events
FiledFormWhat it isAccession number
2022-11-3016:45 ETDEF 14AProxy statementPeriod 2023-01-040001683168-22-008106
2022-11-1617:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001683168-22-007821
2022-11-1017:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-22-007530
2022-11-1017:01 ET10-QQuarterly reportPeriod 2022-09-300001683168-22-007528
2022-09-2908:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-22-006665
2022-08-2616:05 ET8-K3.01 Delisting notice0001683168-22-006086
2022-08-1216:15 ET8-K5.07 Shareholder vote results0001683168-22-005634
2022-08-1117:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-22-005566
2022-08-1116:51 ET10-QQuarterly reportPeriod 2022-06-300001683168-22-005565
2022-06-3016:30 ETDEF 14AProxy statementPeriod 2022-08-090001683168-22-004728
2022-05-1217:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-22-003517
2022-05-1216:51 ET10-QQuarterly reportPeriod 2022-03-310001683168-22-003516
2022-05-1017:00 ET8-K5.02 Departure or appointment of officers or directors0001683168-22-003391
2022-05-0207:30 ET8-K5.01 Change in control; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001683168-22-003069
2022-04-2916:45 ET10-K/AAnnual report, amendedPeriod 2021-12-310001683168-22-003052
2022-03-2217:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-22-001835
2022-03-2217:00 ET10-KAnnual reportPeriod 2021-12-310001683168-22-001833
2022-03-0317:15 ET8-K3.01 Delisting notice; 9.01 Financial statements and exhibits0001683168-22-001424
2021-11-1016:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-21-005423
2021-11-1016:31 ET10-QQuarterly reportPeriod 2021-09-300001683168-21-005420
2021-08-1217:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-21-003479
2021-08-1217:01 ET10-QQuarterly reportPeriod 2021-06-300001683168-21-003476
2021-06-2116:45 ET8-K5.07 Shareholder vote results0001683168-21-002649
2021-05-1317:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-21-001972
2021-05-1317:08 ET10-QQuarterly reportPeriod 2021-03-310001683168-21-001971
2021-04-3017:00 ETDEF 14AProxy statementPeriod 2021-06-150001683168-21-001666
2021-03-2517:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-21-001063
2021-03-2517:15 ET10-KAnnual reportPeriod 2020-12-310001683168-21-001062
2021-02-1716:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-21-000600
2021-01-2517:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-21-000249
2020-11-1017:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-20-003810
2020-11-1017:00 ET10-QQuarterly reportPeriod 2020-09-300001683168-20-003809
2020-10-1316:30 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001683168-20-003428
2020-08-2817:00 ETDEF 14AProxy statementPeriod 2020-10-080001683168-20-002903
2020-08-1217:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-20-002650
2020-08-1217:00 ET10-QQuarterly reportPeriod 2020-06-300001683168-20-002649
2020-07-0917:20 ETS-1Registration statement0001683168-20-002231
2020-05-2817:15 ETS-1/ARegistration statement, amended0001683168-20-001772
2020-05-1217:11 ETS-1Registration statement0001683168-20-001524
2020-05-1216:36 ET8-K2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits0001683168-20-001520
2020-05-1216:36 ET10-QQuarterly reportPeriod 2020-03-310001683168-20-001519
2020-04-0217:00 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-20-001071
2020-03-2617:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001683168-20-000971
2020-03-2617:25 ET10-KAnnual reportPeriod 2019-12-310001683168-20-000969
2020-03-1216:15 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-20-000783
2020-02-1317:25 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-20-000483
2020-02-1008:00 ET8-K8.01 Other events0001683168-20-000420
2020-02-0714:30 ETS-1/ARegistration statement, amended0001683168-20-000390
2020-02-0617:05 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-20-000378
2020-01-3117:28 ETS-1/ARegistration statement, amended0001683168-20-000317

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.